# BPC-157 and TB-500 for Disc Herniation Recovery: A Complete Protocol Guide
> Note: PeptIQ is not a medical provider. The information in this article is for educational purposes only. Always consult a qualified healthcare professional before starting any supplement or peptide protocol.
Herniated discs are among the most debilitating injuries in the biohacking and fitness community. Standard treatment — rest, physical therapy, NSAIDs, maybe an epidural steroid injection — addresses inflammation and pain but doesn't repair the disc itself. The nucleus pulposus and annulus fibrosus have poor blood supply and limited regenerative capacity on their own.
That's where BPC-157 and TB-500 come in. Together, they target the structural repair mechanisms that conventional medicine largely ignores: collagen synthesis, connective tissue remodeling, angiogenesis at the injury site, and nerve repair.
Understanding the Injury: What Needs to Heal
A herniated disc involves damage to the annulus fibrosus (the outer fibrous ring), often with herniation of the nucleus pulposus (the soft inner material) pressing on nerve roots. Depending on the level (cervical, thoracic, lumbar), this causes radicular pain, numbness, weakness, or combination symptoms.
For recovery, you need:
- Annular repair — re-knitting of the fibrous outer disc tissue
- Anti-inflammatory action — reducing nerve root compression and local swelling
- Nerve repair — regenerating or protecting the compressed nerve fibers
- Vascular support — improving blood supply to an avascular structure
BPC-157 and TB-500 address all four.
BPC-157: The Connective Tissue Repair Workhorse
BPC-157 (Body Protection Compound-157) is a 15-amino acid peptide derived from a protective gastric protein. Its regenerative properties have been validated across hundreds of animal studies covering tendons, ligaments, muscle, bone, and nerve tissue.
How it helps disc herniation specifically:
- Upregulates tendon-related growth factors — BPC-157 activates the Egr-1 transcription factor, which drives collagen synthesis in fibrous tissue including the annulus fibrosus
- Promotes angiogenesis — increases VEGF expression, improving blood supply to the avascular disc environment
- Neuroprotective effects — multiple rodent studies show BPC-157 accelerates peripheral nerve regeneration and protects against nerve compression injury
- Systemic anti-inflammatory — suppresses pro-inflammatory cytokine cascades without the immunosuppressive side effects of steroids
Protocol:
- Dose: 250–500mcg/day subcutaneous injection
- Injection site: Lower abdomen or closest accessible subQ site to the injury (though systemic distribution means proximity matters less than for localized joint issues)
- Duration: 6–8 weeks loading phase, reassess at week 8
Most people notice reduced nerve pain and improved mobility within 2–4 weeks. Structural disc repair is a slower process — expect meaningful improvement at 6–12 weeks.
TB-500: Structural Remodeling and Tissue Mobility
TB-500 (Thymosin Beta-4 fragment) is a synthetic version of the naturally occurring Thymosin Beta-4 protein. Where BPC-157 drives new tissue growth, TB-500 specializes in cellular migration and remodeling — it helps new cells find and fill damaged areas.
How it helps disc herniation:
- Actin regulation — Thymosin Beta-4 sequesters actin monomers and regulates cell migration, which is critical for the movement of repair cells into the avascular disc space
- Reduces fibrotic scarring — promotes healthy tissue remodeling vs. scar tissue formation at the injury site
- Anti-inflammatory — down-regulates NF-κB signaling, one of the key inflammatory pathways active in disc herniations
- Works in synergy with BPC-157 — while BPC-157 creates the growth signals, TB-500 provides the cellular migration framework to execute the repair
Protocol:
- Loading phase: 2.5mg–5mg/week subcutaneous injection for 4–6 weeks
- Maintenance: 1.25–2.5mg/week ongoing
- Frequency: Single weekly injection or split into two 1.25mg injections across the week (both approaches work)
The Synergy: Why Run Both Together
BPC-157 and TB-500 work through different but complementary mechanisms. BPC-157 generates the growth factor signals; TB-500 provides the cellular scaffolding and migration pathway. Running both together produces better outcomes than either alone for structural injuries.
The combination is sometimes called the "recovery stack" in the research peptide community because it addresses both the signaling (BPC-157) and structural remodeling (TB-500) sides of tissue repair simultaneously.
Adding GHK-Cu: The Collagen Layer
GHK-Cu (copper tripeptide) deserves a place in a disc herniation recovery protocol. It's a naturally occurring copper-binding peptide that directly stimulates collagen I, collagen III, and elastin synthesis — the structural proteins that make up the annulus fibrosus.
GHK-Cu also activates more than 4,000 genes involved in tissue repair and turns off genes associated with inflammation and fibrosis. For disc recovery, it works as a background layer that supports the structural repair signals BPC-157 initiates.
Protocol addition:
- GHK-Cu: 1–2mg/day subcutaneous injection
- Can be drawn into the same syringe as BPC-157 (compatible reconstitution solvents)
Full Disc Recovery Protocol: Phased Approach
Because you're managing active injury recovery alongside a return-to-training goal, a phased approach works better than starting everything simultaneously.
Phase 1: Weeks 1–3 (Disc Repair Priority)
- BPC-157: 500mcg/day subQ
- TB-500: 2.5mg/week subQ
- GHK-Cu: 1mg/day subQ
- Focus: disc tissue repair, nerve decompression, anti-inflammation
- Activity: physical therapy, gentle mobility, no loading
Phase 2: Weeks 4–8 (Add Recomp Layer)
- Continue Phase 1 stack
- Add CJC-1295 no DAC + Ipamorelin: 100mcg each, pre-bed
- This layer drives GH pulsatility for tissue remodeling and begins the body recomposition phase
- Activity: begin light lifting as cleared by PT
Phase 3: Weeks 9+ (Maintenance and Fat Loss)
- TB-500: Drop to maintenance 1.25mg/week
- BPC-157: Can drop to 250mcg/day or 5 days/week
- CJC+Ipa: Continue pre-bed
- Optional add: Tesamorelin (1–2mg/day, 5 days/week) for visceral fat and GH optimization — pairs well with CJC+Ipa
- Optional add: Retatrutide for more aggressive fat loss if that's a priority
What to Expect: Recovery Timeline
Weeks 1–2: Reduced acute nerve pain is often the first noticeable change. BPC-157's anti-inflammatory and neuroprotective effects work faster than structural repair.
Weeks 3–6: Range of motion improvement, less radicular symptoms during physical therapy, improved sleep (disc pain often disrupts sleep posture).
Weeks 6–12: Structural improvement — this is where the disc tissue repair becomes meaningful. Most people notice significantly better function under load.
Post-protocol: The tissue repair persists. Unlike pain medications that mask symptoms, BPC-157 and TB-500 create actual structural change. Coming off the peptides doesn't reverse the repair that occurred.
Regression Concern: What Stays When You Stop
A common worry is losing progress after stopping peptides. Here's what actually happens:
- BPC-157 and TB-500: Structural tissue repair is permanent — new collagen and remodeled disc tissue doesn't un-heal when you stop the peptides. You keep the repair.
- CJC+Ipa: Growth hormone axis returns to your natural baseline. Muscle gained while running them stays as long as training and protein intake stay consistent. No dependency or withdrawal.
- Tesamorelin/Reta: Fat lost during GLP-1/GHRH protocol stays off as long as caloric habits hold. Some patients on GLP-1 therapy see regain when stopped if dietary habits weren't changed — this is a habits issue, not a compound dependency.
The short version: invest in the habit changes while the peptides are doing their work, and the outcomes persist.
Reconstitution and Dosing Calculator
Use the peptiq.io reconstitution calculator for exact BAC water math on your vial sizes and target doses.
Quick reference:
- BPC-157 (5mg vial + 2mL BAC water = 2.5mg/mL → draw 20 units for 500mcg)
- TB-500 (10mg vial + 2mL BAC water = 5mg/mL → draw 5 units for 250mcg, 10 units for 500mcg)
- GHK-Cu (50mg vial + 5mL BAC water = 10mg/mL → draw 10 units for 1mg)
BPC-157 and GHK-Cu can be drawn into the same syringe immediately before injection (different vials, same draw).
Frequently Asked Questions
Q: Should I inject near the injury site or anywhere subQ?
For disc injuries, systemic distribution via lower abdomen is standard. BPC-157 works systemically — proximity to the spine for subQ injection is less important than consistent daily dosing.
Q: Can I run this protocol while in physical therapy?
Yes — the peptide protocol and physical therapy are complementary. PT addresses mobility, muscle activation, and functional movement patterns. BPC-157 and TB-500 address the underlying tissue. Running both simultaneously accelerates recovery better than either alone.
Q: How do I know if it's working?
Track: (1) radicular pain on a scale of 1–10 daily, (2) range of motion (how far you can flex forward/rotate), (3) sleep quality. Most people notice changes in all three by week 3–4.
Q: Is there any interaction with NSAIDs or other pain medications?
No documented interactions at typical research doses. Some practitioners recommend minimizing NSAIDs while on BPC-157 since NSAIDs can blunt the growth factor responses BPC-157 initiates. Tylenol/acetaminophen is a cleaner option for pain management during the protocol.
Q: Where do I source these peptides?
In the US: American Peptide Research is a commonly used source in the research community.
---
Track Your Recovery Protocol With PeptIQ
Recovery from a disc herniation takes 8–12 weeks of consistent protocol work. PeptIQ helps you log daily doses, track pain and mobility trends, and see what's actually working over a full recovery cycle.
Download PeptIQ — Premium subscription.